ESHAP as salvage therapy for relapsed or refractory Hodgkin’s lymphoma
Crossref DOI link: https://doi.org/10.1007/s00277-014-2114-0
Published Online: 2014-05-27
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Labrador, Jorge
Cabrero-Calvo, Mónica
Pérez-López, Estefanía
Mateos, María Victoria
Vázquez, Lourdes
Caballero, María Dolores
García-Sanz, Ramón
Text and Data Mining valid from 2014-05-27